<strong>Application of Angiopep-2 Modified Nanoparticles Loaded With Various Drugs in Glioma</strong>

Abstract

Abstract:Glioma is a common primary intracranial tumor, the main reason why it is difficult to cure is that the blood-cerebrospinal fluid barrier prevents the drug from crossing into the brain, thus reducing the drug effective concentration. Secondly, the visible tumor has developed to the middle or late period, missing the right treatment time. Angiopep-2 is a ligand of low density lipoprotein receptor related protein. The LRP is highly expressed on the surface of the blood-cerebrospinal fluid barrier and glioma cells. Angiopep-2 can be modified to the surface of nanoparticles loaded with chemotherapeutic agents or imaging agents, which can achieve targeted drug delivery or significantly improve the imaging effect of glioma. This article reviews the application of the nanoparticles modified with Angiopep-2, providing some ideas and methods for the diagnosis and treatment of glioma.

Key words:Angiopep-2,nanoparticles delivery system,nanoparticles imaging system,glioma

CLC Number:

R739.4

SU Xiao-mei, ZHANG Dan-shen.Application of Angiopep-2 Modified Nanoparticles Loaded With Various Drugs in Glioma[J]. Acta Neuropharmacologica, 2015, 5(6): 57-63.

References

[1] Jason Huse, Eric C Holland. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma[J]. Nat Rev Cancer, 2010, 10(5): 319-331.

[2] Manus J Donahue, Jaishri O Blakeley, Zhou Jin-yuan, et al. Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches[J]. Magn Reson Med, 2008, 59(2): 336-344.

[3] Isaac Yang, Manish Aghi. New advances that enable identification of glioblastoma recurrence[J]. Nat Rev Clin Oncol, 2009, 6(11): 648-657.

[4] Patrick Y Wen, Santosh Kesari. Malignant gliomas in adults[J]. N Engl J Med, 2008, 359(5): 492-507.

[5] Michel Demeule, Anthony Regina, Christian Che, et al. Identification and design of peptides as a new drug delivery system for the brain[J]. J Pharmacol Exp Ther, 2008, 324(3): 1064-1072.

[6] Michel Demeule, Jean-Christophe Currie, Yanick Bertrand, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2[J]. J Neurochem, 2008, 106(4): 1534-1544.

[7] Xin Hong-liang, Jiang Xin-yi, Gu Ji-jin, et al. Angiopep-Conjugated poly(ethyleneglycol)-Co-poly(ε-Caprolactone) nanoparticles as dualtargeting drug delivery system for brain glioma[J]. Biomaterials, 2011, 32(18): 4293-4305.

[8] Conchita Tros de Ilarduya, Sun Yan, Nejat Duzgunes. Gene delivery by lipoplexes and polyplexes[J]. Eur J Pharm Sci, 2010, 40(3): 159-170.

[9] Akiko Eguchi, Bryan R Meade, Yung-Chi Chang, et al. Efficient siRNA delivery into primary cells by a peptide [J]. Nat Biotechnol, 2009, 27(6): 567-571.

[10] Sonia Duarte, Georges Carle, Henrique Faneca, et al. Suicide gene therapy in cancer: where do we stand now?[J]. Cancer Lett, 2012, 324(2): 160-170.

[11] Gao Shi-qian, Tian Hua-yu, Xing Zhen-kai, et al. A non-viral suicide gene delivery system traversing the blood brain barrier for non-invasive glioma targeting treatment[J]. J Control Release, 2016, 243(3): 357-369.

[12] An Sai, He Dong-sheng, Ernst Wagner, et al. Peptide-like polymers exerting effective glioma-targeted siRNA delivery and release for therapeutic application[J]. Small, 2015, 11(38): 5142-5150.

[13] Huang Shi-xian, Li Jian-feng, Han Liang, et al. Dual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for glioma[J]. Biomaterials, 2011, 32(28): 6832-6838.

[14] Dechao Niu, Liu Zuo-jin, Li Yong-sheng, et al. Monodispersed and ordered large-pore mesoporous silica nanospheres with tunable pore structure for magnetic functionalization and gene delivery[J]. Adv Mater, 2014, 26(29): 4947-4953.

[15] Wang Guo-wei, Xu Jun-jun, Guo Man-man, et al. A novel core-shell structural phospholipid- functionalized mesoporous silica nanoparticles modified with angiopep-2 as targeting drug delivery system for brain glioma[C]. 石家庄: 中国药学会, 2014: 1-23.

[16] 曹政红, 龚珉, 兰静, 等. 血脑屏障内低密度脂蛋白受体相关蛋白-1受体的靶向新型多肽ANG1005[J]. 现代药物与临床, 2012, 27(4): 396-399.

[17] Regina A, Demeule M, Che C, et al. Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2[J]. Br J Pharmacol, 2008, 155(2): 185-97.

[18] Wang Lei, Hao Yong-wei, Li Hai-xia, et al. Co-delivery of doxorubicin and siRNA for glioma therapy by a brain targeting system: angiopep-2-modified poly (lactic-co-glycolic acid) nanoparticles[J]. J Drug Target, 2015, 23(9): 832-846.

[19] Claudia Scaringi, Riccardo Maurizi Enrici, Giuseppe Minniti. Combining molecular targeted agents with radiation therapy for malignant gliomas[J]. Oncotargets Ther, 2013, 2013(6): 1079-1095.

[20] Emily S Day, Zhang Lin-na, Patrick A Thompson, et al. Vascular-targeted photothermal therapy of an orthotopic murine glioma model[J]. Nanomedicine, 2012, 7(8): 1133-1148.

[21] Tang Yuan, Lei Ting-jun, Romila Manchanda, et al. Simultaneous delivery of chemotherapeutic and thermal-optical agents to cancer cells by a polymeric (PLGA) nanocarrier: an in vitro study[J]. Pharm Res, 2010, 27(10): 2242-2253.

[22] Hao Yong-wei, Wang Lei, Zhao Ya-lin, et al. Targeted imaging and chemo-phototherapy of brain cancer by a multifunctional drug delivery system[J]. Macromol Biosci, 2015, 15(11): 1571-1585.

[23] Erik C Dreaden, Megan A Mackey, Huang Xiao-hua, et al. Beating cancer in multiple ways using nanogold[J]. Chem Soc Rev, 2011, 40(7): 3391-3404.

[24] Ke Heng-te, Wang Jin-rui, Tong Sheng, et al. Gold nanoshelled liquid perfluorocarbon magnetic nanocapsules: a nanotheranostic platform for bimodal ultrasound/magnetic resonance imaging guided photothermal tumor ablation[J]. Theranostics, 2014, 4(1): 12-23.

[25] Erik C Dreaden, Alaaldin M Alkilany, Huang Xiao-hua, et al. The golden age: gold nanoparticles for biomedicine[J]. Chem Soc Rev, 2012, 41(7): 2740-2779.

[26] Hao Yong-wei, Zhang Bing-xiang, Zheng Cui-xia, et al. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging[J]. J Control Release, 2015, 15(11): 545-555.

[27] Cameron C Lee, Andrew T Cramer, Francis C Szoka, et al. An intramolecular cyclization reactionis responsible for the in vivo inefficacy and apparent pH insensitive hydrolysis kinetics of hydrazone carboxylate derivatives of doxorubicin[J]. Bioconjug Chem, 2006, 17(5):1364-1368.

[28] Wang Feng, Wang Yu-cai, Dou Shuang, et al. Doxorubicin-tethered responsive gold nanoparticles facilitate intracellular drug delivery for overcoming multidrug resistance in cancer cell[J]. ACS Nano, 2011, 5(5): 3679-3692.

[29] Catherine J Murphy, Anand M Gole, John W Stone, et al. Gold nanoparticles in biology: beyond toxicity to cellular imaging[J]. Acc Chem Res, 2008, 41(12): 1721-1730.

[30] Ruan Shao-bo, Yuan Ming-qing, Zhang Li, et al. Tumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticles[J]. Biomaterials, 2015, 37C: 425-435.

[31] Zhou Jin-yuan, Erik Tryggestad, Wen Zhi-bo, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides[J]. Nat Med, 2011, 17(1): 130-134.

[32] Vladimir Torchilin. Tumor delivery of macromolecular drugs based on the EPR effect [J]. Adv Drug Delivery Rev, 2011, 63(3): 131-135.

[33] Siti M Janib, Ara S Moses, J Andrew MacKay. Imaging and drug delivery using theranostic nanoparticles[J]. Adv Drug Deliv Rev, 2010, 62(11): 1052-1063.

[34] Margret Schottelius, Burkhardt Laufer, Horst Kessler, et al. Ligands for mapping alphavbeta3-integrin expression in vivo[J]. Acc Chem Res, 2009, 42(7): 969-980.

[35] Yan Hui-hui, Wang Lu, Wang Ji-yao. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood brain barrier[J]. ACS Nano, 2012, 6(1): 410-420.

[36] Ni Da-long, Zhang Jia-wen, Bu Wen-bo, et al. Dual-targeting upconversion nanoprobes across the blood-brain barrier for magnetic resonance/fluorescence imaging of intracranial glioblastoma[J]. ACS Nano, 2014, 8(2): 1231-1242.

[37] Ryo Suzuki, Tomoko Takizawa, Yoichi Negishi, et al. Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound[J]. J Control Release, 2007, 117(1): 130-136.

[38] Suzuki R, Takizawa T, Negishi Y, et al. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles[J]. J Control Release, 2008, 125(2): 137-144.

[39] Yoko Endo-Takahashi, Kotomi Ooaku, Kazuma Ishida, et al. Preparation of Angiopep-2 peptide-modified bubble liposomes for delivery to the brain[J]. Biol Pharm Bull, 2016, 39(6): 977-983.

[40] Zhao Li-xia, Di Fan, Wang Da-bin, et al. Chemiluminescence of carbon dots under strong alkaline solutions: a novel insight into carbon dot opticla properties[J]. Nanoscale, 2013, 5(7): 2655-2658.

[41] Liu Chang-jun, Zhang Peng, Zhai Xin-yun, et al. Nano-carrier for gene delivery and bioimaging based on carbon dots with PEI-passivation enhanced fluorescence[J]. Biomaterials, 2012, 33(13): 3604-3613.

[42] Shouvik Mitra, Sourov Chandra, Shaheen Hamidkhan Pathan, et al. Room temperature and solvothermal green synthesis of self passivated carbon quantum dots[J]. RSC Advances, 2013, 3(10): 3189-3193.

[43] Ruan Shao-bo, Qian Jun, Shen Shun, et al. Fluorescent carbonaceous nanodots for noninvasive glioma imaging after Angiopep-2 decoration[J]. Bioconjug Chem, 2014, 25(12): 2252-2259.

[44] Silvia Marchesan, Kostas Kostarelos, Alberto Bianco, et al. The winding road for carbon nanotubes in nanomedicine[J]. Mater Today, 2015, 18(1): 12-19.

[45] Naoto Saito, Yuki Usui, Kaoru Aoki, et al. Carbon nanotubes: biomaterial applications[J]. Chem Soc Rev, 2009, 38(7): 1897-1903.

[46] Houmam Kafa, Julie Tzu-Wen Wang, Noelia Rubio, et al. The interaction of carbon nanotubes with an in vitro blood-brain barrier model and mouse brain in vivo[J]. Biomaterials, 2015, 53(3): 437-452.

[47] Michel Demeule, Anthony Regina, Christian Che, et al. Identification and design of peptides as a new drug delivery system for the brain[J]. J Pharmacol Exp Ther, 2008, 324(3): 1064-1072.

[48] Houmam Kafa, Julie Tzu-Wen Wang, Noelia Rubio. Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood-brain barrier in vitro and in vivo[J]. J Control Release, 2016, 225(3): 217-219.

Application of Angiopep-2 Modified Nanoparticles Loaded With Various Drugs in Glioma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles6

Recommended Articles

Metrics

[1]	ZHAO Peng-hui，PANG Ce，ZHEN Pan.A New Idea to Treat Glioma with Mulberin[J]. Acta Neuropharmacologica, 2019, 9(5): 44-49.
[2]	LUO Lin-ming, JI Yi-na, CHEN Nai-hong.Research Progress on the Effect of Neural Stem Cells in the Occurrence and Development of Glioma[J]. ACTA NEUROPHARMACOLOGICA, 2015, 5(5): 28-33.
[3]	HAO Jun-rong，TIAN Yu-qin，SHEN Li-xia.Research Progress of Chemotherapeutics used in the Treatment of Gliomas[J]. Acta Neuropharmacologica, 2013, 3(3): 48-56.
[4]	HAO Jun-rong, SHEN Li-xia.Research Progress of the Effective Constituents of Traditional Chinese Medicine Used in the Treatment of Gliomas[J]. Acta Neuropharmacologica, 2012, 2(5): 57-64.
[5]	RU Qin, TIAN Xiang, CHEN Lin, YUE Kai, MA Bao-miao, LI Chao-ying.Expression Patterns of P2X Receptors in Rat Glioma and Pheochromocytoma[J]. Acta Neuropharmacologica, 2012, 2(4): 1-7.
[6]	JIN Hui, LIU Li-Feng, LIANG Lei, DENG Wei-Ping, LIU Jian-Wen.Research on the block of cell cycle and apoptosis induction on glioma cell line U251 of a novel HDAC inhibitor named DWP0016[J]. Acta Neuropharmacologica, 2011, 1(1): 38-45.